CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
1-Year Est. Return
26.35%
1 Year Est. Return
+26.35%
AUM
$5.08M
AUM Growth
-$11.6M
(-69%)
Holding
15
Top Sells
| 1 | +$6.83M | |
| 2 | +$1.65M | |
| 3 | +$355K | |
| 4 |
CBIO
Crescent Biopharma
CBIO
|
+$50.9K |
Sector Composition
| 1 | Healthcare | 87.74% |
| 2 | Financials | 4.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rezolute
RZLT
$806M
| $3.83M | 75.28% |
1,318,967
|
|
||
2
SPDR Gold Trust
GLD
$135B
| $374K | 7.36% |
1,298
+129
|
|
||
3
Berkshire Hathaway Class B
BRK.B
$1.05T
| $249K | 4.9% |
467
-666
|
|
||
4
MindMed
MNMD
$906M
| $199K | 3.92% |
34,073
|
|
||
|
BCAX
5
Bicara Therapeutics
BCAX
$1.02B
| $143K | 2.81% |
10,941
|
|
||
6
Compass Therapeutics
CMPX
$776M
| $82.6K | 1.63% |
43,465
|
|
||
7
Lexeo Therapeutics
LXEO
$474M
| $61.9K | 1.22% |
17,851
|
|
||
8
Kyverna Therapeutics
KYTX
$303M
| $44.4K | 0.87% |
22,981
|
|
||
9
Cardiff Oncology
CRDF
$149M
| $41.7K | 0.82% |
13,287
|
|
||
10
Inhibikase Therapeutics
IKT
$113M
| $35.9K | 0.71% |
16,393
|
|
||
11
Adicet Bio
ACET
$159M
| $13.2K | 0.26% |
17,488
|
|
||
12
Context Therapeutics
CNTX
$113M
| $11.3K | 0.22% |
18,403
|
|
||
|
CBIO
13
Crescent Biopharma
CBIO
$207M
| – | – |
-2,036
|
|
||
14
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
-2,823
|
|
||
15
Xeris Biopharma Holdings
XERS
$1.48B
| – | – |
-2,015,157
|
|